Overall, grade 3–4 lymphopenia was shown to occur in the majority of patients receiving standard-of-care treatment, with severe lymphopenia being an independent predictor of poor survival (29), and immune cell modulation was shown to be mostly restricted to CD4 T cells and B lymphocytes (21, 26). Here, CD4 is linked to lymphopenia.